Sort by

Search results

Displaying 51 - 39 of 39 results.

Biomedical Research and the Commercialization Agenda: A Review of main Considerations for Neuroscience

T. Caulfield and Ogbogu, U., Biomedical Research and the Commercialization Agenda: A Review of main Considerations for Neuroscience, Accountability in Research: Policies & Quality Assurance, vol. 15, no. 4, pp. 303-320, 2008.

Researchers’ Views of the Acceptability of Restrictive Provisions in Clinical Trial Agreements with Industry Sponsors

M. Mello, Clarridge, B., and Studdert, D., Researchers’ Views of the Acceptability of Restrictive Provisions in Clinical Trial Agreements with Industry Sponsors, Accountability in Research: Policies & Quality Assurance, vol. 12, no. 3, pp. 163-191, 2005.

Ten Steps to Developing a National Agenda to Address Financial Conflicts of Interest in Industry Sponsored Clinical Research

Dr. Cezanne and the Art of Re(peat)search: Competing Interests and Obligations in Clinical Research

R. L. Bluhm, Downie, J., and Nisker, J., Dr. Cezanne and the Art of Re(peat)search: Competing Interests and Obligations in Clinical Research, Accountability in Research: Policies & Quality Assurance, vol. 17, no. 2, pp. 85-95, 2010.

Institutional Academic Industry Relationship: Results of Interviews with University Leaders

E. Campbell, Moy, B., Feibelmann, S., Weissman, J., and Blumenthal, D., Institutional Academic Industry Relationship: Results of Interviews with University Leaders, Accountability in Research: Policies & Quality Assurance, vol. 11, no. 2, pp. 103-118, 2004.

A Tale of Two Perspectives: Regulation Versus Self-Regulation. A Financial Reporting Approach (from Sarbanes–Oxley) for Research Ethics

Pages